mrd to support treatment planning in a young, high-risk all patient
Published 3 years ago • 205 plays • Length 9:20Download video MP4
Download video MP3
Similar videos
-
7:24
mrd helps predict outcomes and informs transplant decision for an all patient
-
4:19
mrd to assess response and inform transplant decision in a relapsed all patient
-
6:32
mrd helps predict outcomes and informs transplant decision for an all patient
-
5:42
initiating consolidation prior to transplant based on mrd positivity in acute lymphoblastic leukemia
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll
-
4:18
rishi's battle with acute lymphoblastic leukemia
-
3:07
minimal residual disease (mrd)
-
2:33
the critical role of minimal residual disease (mrd) throughout the cancer care journey 1080p
-
1:06
karen: multiple myeloma patient discusses clonoseq® mrd testing
-
30:46
asco 2021 clonoseq industry expert theater
-
56:04
minimal residual disease (mrd) overview | lrf ed forum series
-
5:17
approaches to and the use of mrd in all
-
1:04
tim: myeloma patient discusses mrd testing
-
7:39
understanding mrd
-
4:58
role of mrd testing in adult acute lymphocytic leukemia
-
15:02
the evolving landscape of all therapy and the impact of mrd
-
2:57
mrd in aml: prognoses, transplant and treatment planning
-
17:33
adaptive technology - clonoseq - harlan robins, phd
-
2:07
using mrd to improve patient outcomes
-
8:18
mrd & me
-
48:03
ash 2020 product theater: lanny kirsch, md